symplesurgical.net - Renal Sympathetic Denervation | Medical Microwave Ablation Technology and Devices | Symple Surgical Inc., (SSI) | Northern Calif

Description: Symple Surgical Inc., (SSI) is a developer of novel ablation technologies using controlled Microwave Energy. Symple Surgical innovation is for the treatment of resistant hypertension via renal sympathetic denervation. The DirectAblate Catheter delivers microwave energy to the depth-specific location of the sympathetic nerves while minimizing thermal exposure to non-targeted areas. Offices located in Northern California and Flagstaff, AZ.

ssi (370) medical device product development (6) symple surgical (4) start-up medical device company (4) privately-held medical device company (4) directablate grizzly (4) microwave ablation system (4) barrett’s esophagus (4) automated ablation activation (4) esophageal adenocarcinoma (eac)

Example domain paragraphs

Symple Surgical is an exciting start-up Medical Device company focused on developing novel therapeutic technologies through controlled Microwave Ablation. Our technologies are thoughtfully designed to be familiar and easy to use by the operator while providing automated control, feedback, and safety for the patient.

Symple Surgical’s first product offering is the DirectAblate GRIZZLY TM Microwave Ablation System TM . Through the ground-breaking therapy of directed microwave ablation of pre-cancerous Barrett’s cells, we are focused on helping millions of patients worldwide living with Barrett’s Esophagus and the subsequent advancement to esophageal adenocarcinoma (EAC). While multiple clinical studies have demonstrated that radiofrequency ablation for treatment of Barrett’s Esophagus is incompletely effective in 25% of

Due to the unique characteristics of Microwave Energy, wide-ranging applications for this technology cross-over into the fields of Interventional Cardiology, Electrophysiology, Nephrology, Pulmonology and Vascular Intervention. Symple Surgical has established an exciting pipeline of products targeting growing markets in minimally invasive medicine.